Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).
Meeting Abstract
Overview
Research
Additional Document Info
View All
Overview
cited authors
Jain, Rohit K.; Swami, Umang; Bilen, Mehmet Asim; Boucher, Kenneth M.; Brown, Jacqueline T.; Chahoud, Jad; Gupta, Sumati; Agarwal, Neeraj; Sonpavde, Guru P.; Maughan, Benjamin L.
Publication Date
February 1, 2024
webpage
Web of Science
published in
JOURNAL OF CLINICAL ONCOLOGY
Journal
Research
category
ONCOLOGY
Web of Science Category
keywords
1
130-540-543-4790
171
2
242
261-566-9263
283-183-138-11076
298-145-222-184-1022-9124
3
38092-20072
38092-25535
38092-29187
4
6
613-135-2370-7650-2700
613-7657-304
62
Additional Document Info
start page
539
end page
539
volume
42
issue
4_SUPPL